Results 291 to 300 of about 1,324,041 (317)

Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical Trials.

JAMA Netw Open
McHugh RK, Bailey AJ, McConaghy BA, Weiss RD, Fiellin DA, Hillhouse M, Moore BA, Fitzmaurice GM.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Opioid use disorder

Nature Reviews Disease Primers, 2020
John Strang, Nora D Volkow, Louisa J Degenhardt   +2 more
exaly   +2 more sources

Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review

Substance Use & Misuse, 2021
Introduction Medications for opioid use disorder (MOUD) are evidence-based treatments, yet can be controversial among some populations. This study provides a systematic review of prejudice and discrimination toward MOUD, a form of “intervention stigma,”
E. Madden, Suzanne Prevedel, Timothy J Light, Sandra H. Sulzer   +3 more
semanticscholar   +1 more source

Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-2017.

Addiction, 2022
BACKGROUND AND AIMS Opioid overdose is a leading cause of death during the immediate time after release from jail or prison. Most jails in the United States do not provide methadone and buprenorphine treatment for opioid use disorder (MOUD), and research
Sungwoo Lim, Teena Cherian, M. Katyal, Keith S. Goldfeld, R. McDonald, E. Wiewel, M. Khan, N. Krawczyk, S. Braunstein, Sean M. Murphy, Ali Jalali, Philip J. Jeng, Ross Macdonald, Joshua D. Lee   +13 more
semanticscholar   +1 more source

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.

American Journal of Psychiatry, 2022
OBJECTIVE Extensive exposure to prescription-type opioids has resulted in major harm worldwide, calling for better-adapted approaches to opioid agonist therapy.
Didier Jutras-Aswad, B. Le Foll, K. Ahamad, Ronald Lim, J. Bruneau, Benedikt Fischer, Jürgen Rehm, T. Wild, Evan Wood, S. Brissette, Lea Gagnon, Jill Fikowski, Omar Ledjiar, Benoît Mâsse, M. Socías   +14 more
semanticscholar   +1 more source

Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review.

JAMA Internal Medicine
Importance The rise of fentanyl and other high-potency synthetic opioids across US and Canada has been associated with increasing hospitalizations and unprecedented overdose deaths.
Honora Englander, Ashish P. Thakrar, Sarah M. Bagley, T. Rolley, Kathryn Dong, Elaine Hyshka   +5 more
semanticscholar   +1 more source

Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.

Health Affairs, 2021
Social discourse about the opioid crisis in the US has focused on White populations, even though opioid-related deaths have grown at a higher rate among people of color than among non-Hispanic White people in recent years.
B. Andraka-Christou
semanticscholar   +1 more source

Team approach for nonmedical opioid use

Ca-A Cancer Journal for Clinicians, 2023
exaly  

Behavioral interventions alter urologists' opioid prescribing practices

Ca-A Cancer Journal for Clinicians, 2021
exaly